Comparing remimazolam and midazolam for sedation during upper GI endoscopy
Official title: Remimazolam Versus Midazolam for Sedation During Upper GI Endoscopy: a Randomized Controlled Trial
Run by St. Antonius Hospital · NCT06614036 · Data updated 2026-11-12
This study tests whether a new sedative called remimazolam helps people recover faster and feel better after an upper GI endoscopy compared to the standard sedative, midazolam.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 148 (estimated) |
| Sponsor | St. Antonius Hospital Academic / other |
| Locations | 3 sites (Apeldoorn, Gelderland and 2 other locations) |
| Status | Recruiting |
| Started | October 21, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | April 30, 2026 |
| Registry record updated | December 4, 2024 |
| Trial ID | NCT06614036 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 years and older who are scheduled for a diagnostic upper GI endoscopy requiring procedural sedation.
✕Probably not a fit
Patients who are anticipated to require opioids during the procedure or have a high ASA score (4) may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of remimazolam and midazolam as sedatives during diagnostic upper gastrointestinal endoscopies. The study will randomly assign participants to receive either sedative and measure key outcomes such as time to full alertness and patient satisfaction. By evaluating these parameters, the trial seeks to determine if remimazolam can provide a faster recovery and improved post-procedural memory compared to the standard sedative, midazolam.
Why it matters
Potential benefit: If successful, this study could lead to improved sedation practices, allowing for quicker recovery times and enhanced patient satisfaction during and after endoscopic procedures.
How similar studies have gone: Previous studies have shown promising results with remimazolam, indicating its potential advantages over traditional sedatives like midazolam, making this approach both relevant and timely.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients age ≥ 18 years. * Scheduled for a diagnostic upper GI endoscopy with procedural sedation. * Ability to provide written informed consent, and to understand the responsibilities of trial participation. Exclusion Criteria: * Anticipated use of opioids, such as a therapeutic endoscopy or any other reason. * ASA score of 4. * Subject has a known history of unresolved drug or alcohol dependency that would limit ability to comprehend or follow instructions related to informed consent.
Where it's running
-
Gelre Hospitals
Apeldoorn, Gelderland, Netherlands Recruiting -
Rijnstate hospital
Arnhem, Gelderland, Netherlands Recruiting -
St Antonius hospital
Nieuwegein, Utrecht, Netherlands Recruiting
Study contacts
- Study coordinator: Koen Munters, MD
- Email: k.munters@antoniusziekenhuis.nl
- Phone: +31 088 755 07 21
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hybrid heart failure care with home monitoring
This study tests whether a hybrid care pathway with remote monitoring helps adults with heart failure compared to usual care.
-
Non-invasive detection of right-to-left shunts with the SONAS headband
This will test whether the SONAS headband can find right-to-left shunts in adults with hereditary hemorrhagic telangiectasia (HHT) who are already having a bubble heart ultrasound (TTCE).
-
Using indocyanine green to find sentinel lymph nodes during mastectomy
This pilot will test whether injecting indocyanine green and using fluorescence during mastectomy can find sentinel lymph nodes in women with clinically node-negative invasive breast cancer.
-
Timing of hip fracture surgery for patients on DOAC blood thinners
This project will see if operating within 24 hours is as safe as delaying surgery for people with hip fractures who recently took DOAC blood thinners by comparing how often they need blood transfusions.
-
Using repeated MRI and PSA to reduce overdiagnosis and avoid unnecessary prostate biopsies
This approach tests whether regular PSA checks and repeat MRI for men with moderate prostate cancer risk can safely delay biopsies and reduce unnecessary procedures.
-
Daily online hypnosis exercises to improve mental health and self-esteem in 10-11-year-olds
We test whether listening to short online hypnosis recordings each schoolday for six weeks helps 10-11-year-old children improve self-esteem and resilience and reduces their risk of anxiety or depression later on.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.